In a recent study published in JAMA, researchers evaluate the efficacy of ivermectin in a maximum dosage of 600 μg/kg/day over six days in treating early mild-to-moderate coronavirus disease 2019 ...
SEATTLE -- A higher dose of ivermectin given for a longer duration still failed to offer any benefit in mild to moderate COVID-19, data from a large randomized U.S. trial showed. In the ACTIV-6 trial ...
Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. Ivermectin is no more effective than placebo in reducing the severity of COVID-19 among newly ...
WASHINGTON -- There were no differences in relief from mild-to-moderate COVID-19 symptoms for patients on ivermectin versus placebo, according to the ongoing ACTIV-6 trial. Among >1,000 vaccinated and ...
During the COVID-19 pandemic, ivermectin was promoted by some as an alternative treatment, leading to misinformation and warnings from health agencies. A sign cautions Ivermectin use on Sept. 7, 2021, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results